NASDAQ:ATXI

Avenue Therapeutics - ATXI Institutional Ownership

$8.47

-6.03 (-41.59%)

(As of 10/5/2022 05:11 PM ET)

Add

Compare

Today's Range: $8.12
▼
$10.50
50-Day Range: $3.21
▼
$67.50
52-Week Range: $3.00
▼
$27.75

Volume: 2.70 million shs
Average Volume: 874,486 shs
Market Capitalization: $12.43 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Current Institutional Ownership Percentage: 10.87%
Number of Institutional Buyers (last 12 months): 3
Total Institutional Inflows (last 12 months): $1.42 M
Number of Institutional Sellers (last 12 months): 1
Total Institutional Outflows (last 12 months): $1.07 M

ATXI Institutional Buying and Selling by Quarter

Get ATXI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Avenue Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Avenue Therapeutics Major Shareholders & Ownership History

Export to Excel

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/13/2022	Renaissance Technologies LLC	124,400	$34K	0.0%	N/A	0.572%
5/17/2022	Virtu Financial LLC	58,004	$28K	0.0%	N/A	0.267%
1/28/2022	National Asset Management Inc.	71,338	$65K	0.0%	-20.1%	0.376%
11/16/2021	National Asset Management Inc.	89,237	$0.13M	0.0%	-29.2%	0.531%
10/19/2021	Kestra Advisory Services LLC	22,500	$34K	0.0%	N/A	0.134%
9/17/2021	Virtu Financial LLC	26,373	$66K	0.0%	N/A	0.157%
9/3/2021	Parametric Portfolio Associates LLC	10,554	$26K	0.0%	-59.2%	0.063%
8/16/2021	Occudo Quantitative Strategies LP	14,398	$36K	0.0%	N/A	0.086%
8/13/2021	Renaissance Technologies LLC	78,314	$0.20M	0.0%	N/A	0.468%
8/13/2021	Northern Trust Corp	13,767	$35K	0.0%	-82.1%	0.082%
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
8/13/2021	Geode Capital Management LLC	79,556	$0.20M	0.0%	-40.0%	0.475%
8/13/2021	Vanguard Group Inc.	449,982	$1.13M	0.0%	-35.5%	2.687%
8/12/2021	XTX Topco Ltd	10,864	$27K	0.0%	N/A	0.065%
8/12/2021	Advisory Services Network LLC	35,121	$88K	0.0%	N/A	0.210%
8/12/2021	Ergoteles LLC	30,400	$76K	0.0%	N/A	0.182%
8/10/2021	National Asset Management Inc.	126,037	$0.32M	0.0%	-26.1%	0.753%
5/20/2021	Axiom Investment Management LLC	10,000	$60K	0.0%	N/A	0.060%
5/19/2021	Squarepoint Ops LLC	11,668	$71K	0.0%	N/A	0.070%
5/17/2021	Goldman Sachs Group Inc.	17,319	$0.11M	0.0%	N/A	0.103%
5/13/2021	Trexquant Investment LP	13,874	$84K	0.0%	N/A	0.083%
5/13/2021	Axiom Investment Management LLC	10,000	$60K	0.0%	N/A	0.060%
5/13/2021	Barclays PLC	5,568	$34K	0.0%	+159.0%	0.033%
5/12/2021	Northern Trust Corp	77,049	$0.47M	0.0%	-6.8%	0.460%
5/12/2021	Geode Capital Management LLC	132,594	$0.80M	0.0%	+5.9%	0.792%
2/24/2021	Virtu Financial LLC	17,469	$0.10M	0.0%	N/A	0.104%
2/19/2021	JPMorgan Chase & Co.	17,102	$0.10M	0.0%	+260.2%	0.102%
2/17/2021	Jane Street Group LLC	13,288	$79K	0.0%	N/A	0.079%
2/11/2021	Northern Trust Corp	82,691	$0.49M	0.0%	+2.1%	0.494%
2/9/2021	Wells Fargo & Company MN	16,406	$98K	0.0%	-13.2%	0.098%
2/5/2021	BlackRock Inc.	361,486	$2.15M	0.0%	+5.5%	2.158%
2/4/2021	National Asset Management Inc.	167,787	$1M	0.1%	+15.0%	1.002%
11/13/2020	Morgan Stanley	22,706	$0.25M	0.0%	+270.9%	0.136%
11/10/2020	State Street Corp	73,316	$0.79M	0.0%	+9.5%	0.438%
11/9/2020	National Asset Management Inc.	145,887	$1.58M	0.1%	+42.7%	0.871%
11/6/2020	BlackRock Inc.	342,742	$3.71M	0.0%	+7.4%	2.052%
10/20/2020	Nisa Investment Advisors LLC	19,069	$0.21M	0.0%	N/A	0.114%
8/25/2020	Nuveen Asset Management LLC	32,114	$0.35M	0.0%	N/A	0.192%
8/20/2020	Charles Schwab Investment Management Inc.	14,314	$0.16M	0.0%	N/A	0.086%
8/17/2020	Jane Street Group LLC	14,010	$0.15M	0.0%	N/A	0.084%
8/14/2020	Bank of America Corp DE	2,694	$29K	0.0%	-62.0%	0.016%
8/12/2020	American International Group Inc.	4,075	$44K	0.0%	N/A	0.024%
8/12/2020	Bank of New York Mellon Corp	15,032	$0.16M	0.0%	N/A	0.090%
8/7/2020	New York State Common Retirement Fund	9,000	$97K	0.0%	N/A	0.054%
7/31/2020	National Asset Management Inc.	102,200	$1.10M	0.1%	+6.5%	0.613%
7/31/2020	UBS Group AG	6,328	$68K	0.0%	+216.4%	0.038%
7/31/2020	Mackay Shields LLC	25,300	$0.27M	0.0%	N/A	0.152%
5/18/2020	Advisor Group Holdings Inc.	33,745	$0.30M	0.0%	N/A	0.202%
5/15/2020	Squarepoint Ops LLC	19,410	$0.17M	0.0%	N/A	0.116%
5/15/2020	Morgan Stanley	4,691	$42K	0.0%	+47.3%	0.028%
5/14/2020	Geode Capital Management LLC	70,115	$0.63M	0.0%	+3.2%	0.420%

5/9/2020	National Asset Management Inc.	96,000	$0.86M	0.1%	+25.9%	0.576%
5/1/2020	BlackRock Inc.	47,057	$0.42M	0.0%	+7.9%	0.282%
2/13/2020	Renaissance Technologies LLC	12,553	$0.12M	0.0%	N/A	0.075%
2/10/2020	National Asset Management Inc.	76,250	$0.73M	0.1%	+3.4%	0.458%
11/27/2019	Squarepoint Ops LLC	12,726	$76K	0.0%	N/A	0.076%
8/13/2019	BlackRock Inc.	39,933	$0.25M	0.0%	+135.7%	0.241%
8/5/2019	National Asset Management Inc.	64,750	$0.41M	0.0%	+9.3%	0.391%
5/8/2019	National Asset Management Inc.	59,250	$0.28M	0.0%	-10.6%	0.358%
5/7/2019	Spark Investment Management LLC	30,500	$0.14M	0.0%	N/A	0.184%
2/14/2019	Opaleye Management Inc.	496,000	$2.68M	1.0%	N/A	4.649%
2/12/2019	Northern Trust Corp	14,568	$79K	0.0%	N/A	0.137%
2/8/2019	National Asset Management Inc.	66,250	$0.36M	0.1%	+4.7%	0.621%

(Data available from 1/1/2016 forward)

ATXI Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ATXI shares?: During the previous two years, 24 institutional investors and hedge funds held shares of Avenue Therapeutics. The most heavily invested institutionals were BlackRock Inc. ($2.15M), Vanguard Group Inc. ($1.13M), State Street Corp ($0.79M), Morgan Stanley ($0.25M), Nisa Investment Advisors LLC ($0.21M), Geode Capital Management LLC ($0.20M), and Goldman Sachs Group Inc. ($0.11M).Learn more on ATXI's institutional investors.
What percentage of Avenue Therapeutics stock is owned by institutional investors?: 10.87% of Avenue Therapeutics stock is owned by institutional investors. Learn more on ATXI's institutional investor holdings.
Which institutional investors have been buying Avenue Therapeutics stock?: Of the 21 institutional investors that purchased Avenue Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Renaissance Technologies LLC ($0.20M), Virtu Financial LLC ($0.10M), National Asset Management Inc. ($65.59K), BlackRock Inc. ($42.32K), Advisory Services Network LLC ($35.12K), Ergoteles LLC ($30.40K), and Kestra Advisory Services LLC ($22.50K).

How much institutional buying is happening at Avenue Therapeutics?: Institutional investors have bought a total of 668,756 shares in the last 24 months. This purchase volume represents approximately $40.87M in transactions.
Which Avenue Therapeutics major shareholders have been selling company stock?: The following institutional investors have sold Avenue Therapeutics stock in the last 24 months: Vanguard Group Inc. ($0.25M), National Asset Management Inc. ($99.15K), Northern Trust Corp ($68.92K), Geode Capital Management LLC ($53.04K), Parametric Portfolio Associates LLC ($15.31K), and Wells Fargo & Company MN ($2.50K).
How much institutional selling is happening at Avenue Therapeutics?: Institutional investors have sold a total of 487,075 shares in the last 24 months. This volume of shares sold represents approximately $17.78M in transactions.

This page (NASDAQ:ATXI) was last updated on 10/5/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms